Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linh Truong

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2020
A Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic LymphohistiocytosisFlorian Gothe, Catherine F Hatton, Linh Truong, et al.
Practical Radiation Oncology|August 2, 2015
Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancerShyam K Tanguturi, Yulia Lyatskaya, Yuhui Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
The identification of potent, selective, and bioavailable cathepsin S inhibitorsJacques Yves Gauthier, W Cameron Black, Isabelle Courchesne, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Identification of a potent and selective non-basic cathepsin K inhibitorChun Sing Li, Denis Deschenes, Sylvie Desmarais, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonistsDaniel Guay, Christian Beaulieu, Michel Belley, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2011
Difluoroethylamines as an amide isostere in inhibitors of cathepsin KElise Isabel, Christophe Mellon, Michael J Boyd, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KJacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitorElise Isabel, Kevin P Bateman, Nathalie Chauret, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseasesMichel Gallant, Christian Beaulieu, Carl Berthelette, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)W Cameron Black, Abbas Abdoli, Xiuli An, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2020
A Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic LymphohistiocytosisFlorian Gothe, Catherine F Hatton, Linh Truong, et al.
Practical Radiation Oncology|August 2, 2015
Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancerShyam K Tanguturi, Yulia Lyatskaya, Yuhui Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
The identification of potent, selective, and bioavailable cathepsin S inhibitorsJacques Yves Gauthier, W Cameron Black, Isabelle Courchesne, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Identification of a potent and selective non-basic cathepsin K inhibitorChun Sing Li, Denis Deschenes, Sylvie Desmarais, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonistsDaniel Guay, Christian Beaulieu, Michel Belley, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2011
Difluoroethylamines as an amide isostere in inhibitors of cathepsin KElise Isabel, Christophe Mellon, Michael J Boyd, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KJacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitorElise Isabel, Kevin P Bateman, Nathalie Chauret, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseasesMichel Gallant, Christian Beaulieu, Carl Berthelette, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)W Cameron Black, Abbas Abdoli, Xiuli An, et al.
Pageof 7